Elisabetta Abruzzese

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Elisabetta Abruzzese

Mar 27, 2025, 07:24 | Drugs

Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis - Mount Sinai Department of Medicine

Mount Sinai Department of Medicine shared a post on LinkedIn: "John Mascarenhas, MD, discusses his…

Mar 11, 2025, 07:54 | Science

Raajit Rampal: Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis

Raajit Rampal, an Associate Member at the Memorial Sloan Kettering Cancer Center, recently shared on…

Aug 8, 2024, 10:24 | Blog

Talha Badar: Advance line of TKI vs allogenic stem cell transplantation in resistant CML

Talha Badar shared a post on X: ''Treatment of resistant chronic myeloid leukemia (CML); advanced…

Jul 30, 2024, 13:23 | Insight

Treatment of CML in pregnant patients and patients who are breastfeeding

FDA Oncology shared on X: An expert panel convened by FDA provides perspectives on drug…

All: 4 Posts: 1 - 100

'

Who From Oncology is Featured in TIME100 Health 2025?

'

Francesco Acerbi and Testicular Cancer: The Defender's Fight and Triumphant Return to Football

'

Yvonne Award for Breakthrough Research 2024 Recipient to Time100 Health List

'

Dr Saunthari Somasundaram is the new President-Elect of the NCD Alliance

'

Does Plastic Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023